Patent directory · USPTO A61K / A61P
Patents matching “RedHill Biopharma Ltd.”
40 pharma patents match "RedHill Biopharma Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 40 pharmaceutical patents matching "RedHill Biopharma Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12370206
Therapy for inhibition of single-stranded RNA virus replication
granted -
US 12115150
Biomarkers of coronavirus pneumonia
granted -
US 11931463
All-in-one fixed-dose combination for treating Helicobacter pylori infection
granted -
US 11918560
Serine protease inhibitor for treating coronavirus infection
granted -
US 11878011
Method for eradicating Helicobacter pylori infection in patients regardless of body mass index
granted -
US 11786541
Inhibitor of sphingosine kinase 2 for treating Ebola
granted -
US 11633385
Combination compositions for treatment of cancer
granted -
US 11590154
Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections
granted -
US 11471448
Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia
granted -
US 11364227
Sphingosine kinase 2 inhibitor for treating coronavirus infection
granted -
US 11135172
Rifabutin-based compositions and methods for treating Helicobacter pylori infection
granted -
US 11090325
Compositions for treating ebola virus infection
granted -
US 11090326
Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine
granted -
US 11058671
Formulations and methods of manufacturing formulations for use in colonic evacuation
granted -
US 11052073
Sphingosine kinase 2 inhibitor for treating coronavirus infection
granted -
US 11045453
Serine protease inhibitor for treating coronavirus infection
granted -
US 10946000
Method for treating cancer with combination therapy
granted -
US 10898439
Methods for treating helicobacter pylori infection
granted -
US 10765691
Method for treating crohn's disease using triple antimicrobial all-in-one formulation
granted -
US 10668050
Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome
granted -
US 10543222
Therapy for inhibition of single-stranded RNA virus replication
granted -
US 10493065
Formulations and methods of manufacturing formulations for use in colonic evacuation
granted -
US 10463654
Combination therapies for treating cancer
granted -
US 10434114
Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics
granted